샘플 요청 목록

 카트 문의
시장보고서
상품코드
1986703

신경 진단 시장 규모, 점유율, 동향 분석 : 기술별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Neurodiagnostics Market Size, Share & Trends Analysis Report By Technology (Neuroimaging Technologies (Computed Tomography, Magnetic Resonance Imaging)), By End Use, By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ￦ 8,927,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ￦ 10,427,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ￦ 13,428,000
카드담기
※ 부가세 별도
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신경 진단 시장 요약

세계의 신경 진단 시장 규모는 2025년에 190억 1,000만 달러로 추계되며, 2033년까지 365억 7,000만 달러에 달할 것으로 예측되고 있으며, 2026-2033년에 CAGR 8.52%로 성장할 것으로 전망되고 있습니다.

이러한 성장은 주로 간질, 알츠하이머병, 파킨슨병, 뇌졸중, 우울증과 같은 신경질환의 유병률 증가에 의해 주도되고 있으며, 이는 정확하고 빠른 진단 솔루션에 대한 지속적인 수요를 창출하고 있습니다.

또한 노인들은 신경퇴행성 질환이나 뇌혈관 질환에 걸리기 쉽기 때문에 노인 인구의 증가도 시장 확대에 큰 기여를 하고 있습니다.

AI 통합 영상 진단, 휴대용 뇌파(EEG) 장치, 고해상도 MRI 및 CT 시스템과 같은 기술의 발전으로 진단 정확도와 워크플로우의 효율성이 향상되어 병원 및 진단센터에서의 도입이 더욱 가속화되고 있습니다.

신경 영상 기술의 발전과 시장 주요 업체들의 혁신적이고 새로운 기술 도입은 시장 성장을 더욱 견인할 것으로 예상됩니다. 예를 들어 지멘스 헬스인어스는 지난 1월 첸나이에서 열린 아시아-오세아니아 방사선 학회(AOCR) 2025에서 최신 진단 영상 기술 혁신을 발표하며, 환자 치료 개선을 위한 안전하고, 접근성이 뛰어나며, 유연하고 지속가능한 기술을 통해 의료를 변화시키겠다는 회사의 약속을 강화했습니다. 라는 회사의 노력을 강화했습니다.

이번 전시회에서는 Dry Cool 기술을 채택하여 사실상 헬륨을 사용하지 않는 1.5T MAGNETOM Flow MRI, 듀얼 소스 CT 스캐너 SOMATOM Pro, 현지 생산 디지털 엑스레이 시스템 'MULTIX Impact E', AI 탑재 초음파 시스템 'ACUSON Maple' 및 'ACUSON Sequoia'도 전시되었습니다. ACUSON Maple' 및 'ACUSON Sequoia'도 전시되었습니다. 이 솔루션들은 특히 다양한 의료 환경에서 진단 정확도를 높이고, 워크플로우를 효율화하며, 고품질 영상 진단에 대한 접근성을 확대할 수 있도록 설계되었습니다.

우울증이 신경 진단 산업의 성장을 주도하고 있습니다. 전 세계에서 증가하는 우울증의 부담으로 인해 질병 기전 규명, 연구 지원, 치료법 선택 지침으로 MRI, PET, EEG 등 객관적인 뇌 평가 툴에 대한 수요가 증가하고 있습니다. 우울증은 전 세계에서 심각한 정신질환이자 장애의 주요 원인 중 하나이기 때문에 고급 신경학적 평가 기술에 대한 임상 및 연구 수요가 지속적으로 발생하고 있습니다. 신경영상 진단 및 신경생리학적 기술은 뇌 회로 변화 연구, 바이오마커 식별 및 개인 맞춤형 치료법 개발을 지원하는 데 사용되고 있으며, 이는 신경진단 기기 및 서비스의 활용을 직접적으로 확장하고 있습니다.

자주 묻는 질문

  • 신경 진단 시장 규모는 어떻게 예측되나요?
  • 신경 진단 시장의 성장은 어떤 요인에 의해 주도되나요?
  • 노인 인구의 증가가 신경 진단 시장에 미치는 영향은 무엇인가요?
  • 신경 진단 기술의 발전은 어떤 방향으로 진행되고 있나요?
  • 우울증이 신경 진단 산업에 미치는 영향은 무엇인가요?
  • 신경 진단 시장의 주요 기업은 어디인가요?

목차

제1장 분석 방법·범위

제2장 개요

제3장 신경 진단 시장 : 변동 요인·동향·범위

제4장 신경 진단 시장 : 기술별 추정·동향 분석

제5장 신경 진단 시장 : 최종 용도별 추정·동향 분석

제6장 신경 진단 시장 : 지역별 추정·동향 분석 : 기술별·최종 용도별)

제7장 경쟁 구도

KSA 26.04.29

Neurodiagnostics Market Summary

The global neurodiagnostics market size was estimated at USD 19.01 billion in 2025 and is projected to reach USD 36.57 billion by 2033, growing at a CAGR of 8.52% from 2026 to 2033. This growth is primarily driven by the increasing prevalence of neurological disorders such as epilepsy, Alzheimer's disease, Parkinson's disease, stroke, and depression, which are creating sustained demand for accurate and early diagnostic solutions.

In addition, the rising geriatric population is significantly contributing to market expansion, as elderly individuals are more susceptible to neurodegenerative and cerebrovascular diseases.

Technological advancements such as AI-integrated imaging, portable EEG devices, and high-resolution MRI and CT systems are improving diagnostic accuracy and workflow efficiency, further accelerating adoption across hospitals and diagnostic centers.

The advancements in neuroimaging technologies and the launch of new and innovative technologies by the key players in the market are further anticipated to drive market growth. For instance, in January 2025, Siemens Healthineers unveiled its latest diagnostic imaging innovations at the Asian Oceanian Congress of Radiology (AOCR) 2025 held in Chennai, strengthening its commitment to transforming healthcare through safe, accessible, flexible, and sustainable technologies that support improved patient care.

The showcase featured the Dry Cool technology-enabled, virtually helium-free 1.5T MAGNETOM Flow MRI, the Dual Source CT scanner SOMATOM Pro. Pulse, the locally manufactured Digital X-ray system MULTIX Impact E, and AI-powered ultrasound systems ACUSON Maple and ACUSON Sequoia. These solutions are designed to enhance diagnostic accuracy, improve workflow efficiency, and expand access to high-quality imaging, particularly across diverse healthcare settings.

Depression drives growth in the neurodiagnostic industry. The rising global burden of depressive disorders is increasing demand for objective brain-based evaluation tools such as MRI, PET, and EEG to better understand disease mechanisms, support research, and guide treatment selection. Depression is a significant mental health disorder worldwide and a leading cause of disability, creating sustained clinical and research demand for advanced neurological assessment technologies. Neuroimaging and neurophysiological techniques are used to study brain circuit changes, identify biomarkers, and support the development of personalized therapies, which directly expands the use of neurodiagnostic equipment and services.

Global Neurodiagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neurodiagnostics market report based on technology, end use, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Neuroimaging Technologies
    • Computed Tomography (CT)
    • Magnetic Resonance Imaging (MRI)
    • Nuclear Medicine Imaging (PET, SPECT)
    • Near infrared spectroscopic imaging (NIRS)
    • Electro-encephalography (EEG)
    • Magneto-encephalography (MEG)
    • Voxel based morphometry (VBM)
  • In Vitro Diagnostics
  • Neuroinformatics
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Imaging Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurodiagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising prevalence of neurological disorders
      • 3.3.1.2. Technological advancements
      • 3.3.1.3. Government and private sector funding
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. High cost of equipment and procedures
      • 3.3.2.2. Limited reimbursement in emerging economies
    • 3.3.3. Market Opportunity Analysis
      • 3.3.3.1. Emergence of portable and point-of-care neurodiagnostic devices
      • 3.3.3.2. Rising adoption in emerging markets
    • 3.3.4. Market Challenge Analysis
      • 3.3.4.1. Data privacy and integration issues
  • 3.4. Neurodiagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Neurodiagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neurodiagnostics Market: Technology Movement Analysis, USD Million, 2025 & 2033
  • 4.3. Neuroimaging Technologies
    • 4.3.1. Neuroimaging Technologies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Computed Tomography (CT)
      • 4.3.2.1. Computed Tomography (CT) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Magnetic Resonance Imaging (MRI)
      • 4.3.3.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Nuclear Medicine Imaging (PET, SPECT)
      • 4.3.4.1. Nuclear Medicine Imaging (PET, SPECT) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Near infrared spectroscopic imaging (NIRS)
      • 4.3.5.1. Near infrared spectroscopic imaging (NIRS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.6. Electro-encephalography (EEG)
      • 4.3.6.1. Electro-encephalography (EEG) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.7. Magneto-encephalography (MEG)
      • 4.3.7.1. Magneto-encephalography (MEG) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.8. Voxel based morphometry (VBM)
      • 4.3.8.1. Voxel based morphometry (VBM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. In Vitro Diagnostics
    • 4.4.1. In Vitro Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Neuroinformatics
    • 4.5.1. Neuroinformatics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Neurodiagnostics Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neurodiagnostics Market: End Use Movement Analysis, USD Million, 2025 & 2033
  • 5.3. Hospitals and Clinics
    • 5.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Diagnostic Laboratories
    • 5.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Imaging Centers
    • 5.5.1. Imaging Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Neurodiagnostics Market: Regional Estimates & Trend Analysis, by Technology and by End Use

  • 6.1. Neurodiagnostics Market Share, By Region, 2025 & 2033, USD Million
  • 6.2. North America
    • 6.2.1. North America Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Neurodiagnostics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Share Analysis, 2025
  • 7.4. Company Profiles
    • 7.4.1. Canon Medical Systems Corporation
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Siemens Healthineers AG
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Koninklijke Philips N.V.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Thermo Fisher Scientific, Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. FUJIFILM Corporation
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Natus Medical Incorporated (ARCHIMED)
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Lifelines Neuro (SIDIS)
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Advanced Brain Monitoring, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. NIHON KOHDEN CORPORATION.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. F. Hoffmann-La Roche Ltd
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. GE HealthCare.
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. Mitsar Co. LTD.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. Deymed Diagnostic
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives
    • 7.4.14. Neurosoft
      • 7.4.14.1. Participant's Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Recent Developments/ Strategic Initiatives
    • 7.4.15. Cadwell Industries
      • 7.4.15.1. Participant's Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Recent Developments/ Strategic Initiatives
    • 7.4.16. Compumedics Limited
      • 7.4.16.1. Participant's Overview
      • 7.4.16.2. Financial Performance
      • 7.4.16.3. Product Benchmarking
      • 7.4.16.4. Recent Developments/ Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제